Drug – bio-affecting and body treating compositions – Extract – body fluid – or cellular material of undetermined...
Reexamination Certificate
2011-03-15
2011-03-15
Richter, Johann R (Department: 1616)
Drug, bio-affecting and body treating compositions
Extract, body fluid, or cellular material of undetermined...
C424S529000, C424S530000, C424S531000, C424S581000
Reexamination Certificate
active
07906149
ABSTRACT:
A method for treating oleoresin induced allergic dermatitis by topically contacting an affected area with a therapeutically effective amount of one or more biopolymers for a sufficient amount of time to enable the one or more biopolymers to have an effect and removing the one or more biopolymers from the affected area. The oleoresin can be urushiol, isosolenopsin A, or a combination thereof. The one or more biopolymer can be albumin. The one or more biopolymers can provide a localized anti-inflammatory effect.
REFERENCES:
patent: 4259318 (1981-03-01), Duhe et al.
patent: 4473495 (1984-09-01), Patterson
patent: 5047249 (1991-09-01), Rothman et al.
patent: 5116964 (1992-05-01), Capon et al.
patent: 5376667 (1994-12-01), Somers et al.
patent: 5620527 (1997-04-01), Kramer et al.
patent: 5686074 (1997-11-01), Stewart
patent: 5702709 (1997-12-01), Schulz et al.
patent: 5767109 (1998-06-01), Sanchez et al.
patent: 5821047 (1998-10-01), Garrard et al.
patent: 5962634 (1999-10-01), Jameson et al.
patent: 6036966 (2000-03-01), Youssefyeh
patent: 6090292 (2000-07-01), Zimmermann et al.
patent: 6423746 (2002-07-01), Yarbrough et al.
patent: 6482831 (2002-11-01), Wynn et al.
patent: 6660901 (2003-12-01), Church
patent: 6667026 (2003-12-01), Goldman et al.
patent: 6696396 (2004-02-01), Arneson
patent: 7008963 (2006-03-01), Yarbrough
patent: 7101851 (2006-09-01), Lowman et al.
patent: 2006/0257441 (2006-11-01), Komai et al.
patent: 2006/0275333 (2006-12-01), Trimble et al.
patent: 1762227 (2007-03-01), None
McClendon et al. ,Fire Ant Venom Alkaloid, Isosolenopsin A, a Potent and Selective Inhibitor of Neuronal Nitric Acid, International Journal of Toxicology, 22:81-86, 2003.
Wiedermann, Anti-inflammtory activity of albumin, Critical Care Medicine, vol. 35 (3),pp. 981—Mar. 2007.
McClendon et al.,Fire Ant Venom Alkaloid, Isosolenopsin A, a Potent and Selective Inhibitor of Neuronal Nitric Acid, International Journal of Toxicology, 22:81-86, 2003.
Wiedermann (Anti-inflammatory activity of albumin, Critical Care Medicine, vol. 35 (3), pp. 981-982, Mar. 2007.
McClendon et al. (Fire Ant Venom Alkaloid, Isosolenopsin A, a Potent and Selective Inhibitor of Neuronal Nitric Acid, International Journal of Toxicology, 22:81-86, 2003.
Wiedermann, Anti-inflammatory activity of albumin, Critical Care Medicine, vol. 35 (3), pp. 981-982, Mar. 2007.
Hawaii Ant Group, “The Red Imported Fire Ant (Solenopsis invicta): A Severe and Imminent Threat to Hawaii,” Feb. 8, 2001.
Pierpoint, W.S., “o-Quinones Former in Plant Extracts,” Biochem. J. (1969), 112, 609.
Ralston, James P., “Fire Ant Bites,” www.emedicine.com, Jan. 17, 2006.
Yi, G. B. et al., “Fire Ant Venom Alkaloid, Isosolenopsin A, a Potent and Selective Inhibitor of Neuronal Nitric Oxide Synthase,” Intl. J. of Toxicology, (2003), 22:81-86.
Zanfel Wash product detail, www.cvs.com, Nov. 6, 2006.
Bos, J. and Meinardi, M., “The 500 Dalton rule for skin penetration of chemical compounds and drugs,” Experimental Dermatology (Jun. 2000), 9:165 (abstract).
Billich, Andreas et al., “Novel cyclosporin derivatives featuring enhanced skin penetration despite increased molecular weight,” Bioorgg. med. chem. (1993), 13:3157 (abstract).
Decision on Appeal from the U.S. Patent and Trademark Office Board of Patent Appeals and Interferences dated Nov. 7, 2008 regarding U.S. Appl. No. 10/405,974.
Boval Company, L.P.
Brooks Kristie L
Hayes and Boone LLP
Richter Johann R
LandOfFree
Method for treating allergic dermatitis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for treating allergic dermatitis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treating allergic dermatitis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2654236